DLL4 and neoplasm: To further investigate the interplay between JAG1 and DLL4 in promoting tumour growth, we used specific anti-DLL4 mAb (MedImm) that recognises both human DLL4 and mouse DLL4 to block DLL4-induced Notch signalling in mJAG1-expressing tumours.